ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,077.78
0.47%
Dow Jones
38,460.92
-0.11%
Gold vs US Dollar
2,321.835
0.23%
Brent Oil
87.27
0.06%
Bitcoin
64,105.84
-0.27%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started

PGN Next Cash Rich Bio-Consolidation Target?

Share Forum
Share On Facebook
Creator eurofox Created 26 Jan 2003 Posts 74 Last Post 18 years ago
Free Annual Reports Add Favourite|E-mail Alert|Related Threads
This company is cash rich - spread has eased a bit - has technology that can speed the trials stages of other drug companies - which is the critical path to their profitability. Any other thoughts?

Your Recent History

LSE
AAU
Ariana Resources
LSE
TERN
Tern
LSE
HUM
Hummingbird Resources
LSE
AAL
Anglo American
LSE
BARC
Barclays
LSE
DEST
Destiny Pharma
LSE
SOLG
Solgold
LSE
ENET
Ethernity Networks
LSE
AET
Afentra
LSE
AAZ
Anglo Asian Mining
LSE
I3E
I3 Energy
LSE
EEE
Empire Metals
LSE
JLP
Jubilee Metals
LSE
BT.A
Bt
LSE
BIRD
Blackbird
LSE
GFM
Griffin Mining
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved